Login

Financial Snapshot

Revenue
TTM
$343.5M
Gross Margin
TTM
70.63%
Net Income
TTM
$20.30M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
424.42%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
217.9M
Cash
2026 Q1
P/E
TTM
27.13
Free Cash Flow
TTM
$39.11M

Stock Price

Loading...
Market Cap: $550.6 Million

About Tactile Systems Technology Inc

Tactile Systems Technology Inc (NASDAQ: TCMD) is a medical device company that develops and sells devices for the treatment of chronic conditions related to lymphedema and chronic venous insufficiency. The filing excerpts available from the 10-K filed 2026-02-17 (accession 000110465926016380) do not contain sufficient financial detail, segment breakdowns, or operational specifics to support a complete canonical description meeting the required standards. The excerpts are limited to boilerplate SEC cover page language, forward-looking statement disclaimers, and a risk factors summary, with no product descriptions, revenue figures, customer data, or competitive information reproduced in full. A complete description cannot be constructed from the provided excerpts without inferring facts not supported by the filing text.

Source: SEC 10-K, filed 2026-02-17

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories Accelerate Diagnostics, Inc Accuray Inc Apyx Medical Inc CVRx, Inc. Owlet Inc RetinalGenix Technologies Inc Sensus Healthcare Inc Stereotaxis Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support